Intelligent Bio Solutions
Yahoo Finance • 17 hours ago
Intelligent Bio Solutions expects to achieve 32.6% Gross Profit Expansion and Increased Profitability on Higher-Margin Sales
Gross profit expected to surge by 32.6% Unaudited revenue of $0.61 million for fiscal Q2 and $1.48 million for the six months ended December 31, 2024 Higher-margin cartridge sales driving profitability and long-term growth Expanding U.S... Full story
Yahoo Finance • 17 hours ago
EXCLUSIVE: Intelligent Bio Solutions Expects To Record Increased Profitability In Q2 On Higher-Margin Sales
EXCLUSIVE: Intelligent Bio Solutions Expects To Record Increased Profitability In Q2 On Higher-Margin Sales On Thursday, Intelligent Bio Solutions Inc. (NASDAQ:INBS) announced preliminary fiscal second-quarter sales of approximately $0.61... Full story
Yahoo Finance • 7 days ago
Intelligent Bio Solutions Expands Global Reach with Multilingual Drug Screening System Upgrade
NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced plans for a... Full story
Yahoo Finance • 9 days ago
Intelligent Bio Solutions Adds Quantum TM to 400+ Account Portfolio Utilizing Breakthrough Fingerprint Drug Testing
Quantum Traffic Management transitions from saliva and urine testing to non-invasive, in-house fingerprint sweat-based drug screening Most recent client added to INBS’s portfolio of more than 400 accounts across the globe, as the Company... Full story
Yahoo Finance • last year
Leading Specialist Material Handling Company, Titan Cranes and Rigging Pty Ltd., Adopts Intelligent Fingerprinting Drug Screening System
NEW YORK, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that Titan C... Full story
Yahoo Finance • last year
Intelligent Bio Solutions Inc. to Present at the Emerging Growth Conference on December 7, 2023
NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it will... Full story
Yahoo Finance • last year
Australian Civil Construction Entity, State Road Constructions, Selects Intelligent Fingerprinting Drug Screening System as Workplace Drug Screening Solution
NEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that success... Full story
Yahoo Finance • last year
Intelligent Bio Solutions Inc. Reports Fiscal 2024 First Quarter Financial Results and Operational Highlights
- First fiscal quarter revenue and government support income increased 191% year-over-year and 88% sequentially due to strong organic growth and execution of expansion plans - - Increased market share organically in existing markets and e... Full story
Yahoo Finance • last year
Intelligent Bio Solutions’ Innovative Drug Screening Technology Now Offered in New Zealand
NEW YORK, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its expansio... Full story
Yahoo Finance • last year
Intelligent Bio Solutions Adds Logistics Firm to Fingerprint Drug Screening Portfolio and Completes Major Milestone with Existing Client
VKVP Haulage adopts Fingerprint Drug Screening System to help drive proactive drug testing policy Auctus Management Group successfully completes 25,000 tests using the Company’s Intelligent Fingerprinting Drug Screening System NEW YORK,... Full story
Yahoo Finance • last year
Intelligent Bio Solutions Inc. Announces Closing of $4.378 Million Underwritten Public Offering Including Partial Exercise of Underwriters’ Overallotment Option
NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the closing of its pre... Full story
Yahoo Finance • last year
Intelligent Bio Solutions Inc. Announces Pricing of $4,000,000 Underwritten Public Offering
NEW YORK, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the pricing of an unde... Full story
Yahoo Finance • last year
Intelligent Bio Solutions Obtains ISO Recertification for its Intelligent Fingerprinting Drug Screening Business
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that its In... Full story
Yahoo Finance • last year
Intelligent Bio Solutions Completes Critical Development Milestone in Plans to Add Ketamine and Tramadol to Fingerprint Drug Test
NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the success... Full story
Yahoo Finance • last year
Intelligent Bio Solutions Inc. Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results and Operational Highlights
- Combined full-year revenue and government support income increased 355% year-over-year - - Received guidance from U.S. FDA on a regulatory pathway for its Intelligent Fingerprinting Drug Screening Cartridge - - Granted 13th patent foll... Full story
Yahoo Finance • 2 years ago
Intelligent Bio Solutions Signs South American Distribution Agreement with TSCOM for Fingerprint Drug Screening System and Secures First Order
NEW YORK, July 06, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company developing and delivering intelligent, rapid, non-invasive testing solutions, today announc... Full story
Yahoo Finance • 2 years ago
Intelligent Bio Solutions Receives Guidance from U.S. FDA on a Regulatory Pathway for Expansion into the United States for its Intelligent Fingerprinting Drug Screening Cartridge
NEW YORK, June 28, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it has recei... Full story
Yahoo Finance • 2 years ago
Intelligent Bio Solutions Receives Non-Dilutive Grant Funding of USD $1.43 Million
NEW YORK, June 20, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it has recei... Full story
Yahoo Finance • 2 years ago
Intelligent Bio Solutions Plans to Add Fentanyl Testing as it Further Enhances its Fingerprint-Based Drug Screening Solution
Lab-testing pathway to expand capabilities of proprietary drug test screening to detect potent opioid fentanyl and fentanyl-adulterated street drugs Opioid crisis estimated to be costing the U.S. $1.5 trillion annually; illicitly manufact... Full story
Yahoo Finance • 2 years ago
Intelligent Bio Solutions Inc. Reports Fiscal 2023 Third Quarter Financial Results and Operational Highlights
- Combined revenue and government support income increased 199% year-over-year - - Sequential revenue growth of 28% - - Filed 513(g) submission with U.S. FDA for Intelligent Fingerprinting Drug Screening Cartridge - - Granted U.K. pat... Full story
